Drug Database
Back to search

Denmark· DK-28107158724

Levomepromazine "Aspire"

A levomepromazine product containing levomepromazinmaleat, registered in Denmark by Aspire Pharma (Malta) Limited. The same ATC class is registered in 16 of our 19 countries.

ATC N05AA02

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedLevomepromazine "Aspire"ATCN05AA02REGISTER NO.DK-28107158724PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levomepromazinmaleatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levomepromazine is registered in 16 of 19 countries.

Countries holding a registration under ATC N05AA02 (levomepromazine), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose
Search levomepromazine products by name

Levomepromazine · ATC N05AA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levomepromazine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.30 in Italy to $6.20 in Switzerland — a ×4.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Levomepromazine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$6.20
  • IT Italy$1.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
LEVOMEPROMAZINMALEAT
Manufacturer
Aspire Pharma (Malta) Limited
Country
Denmark (DK)
ATC code
N05AA02
ATC class
Levomepromazine
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28107158724

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

349 interactions on record for levomepromazine.

Graded by severity as the source publishes them — 44 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check levomepromazine against other medicinesHow interaction checks work

Levomepromazine · interactions on record

349 records

  • 44 severe
  • 263 moderate
  • 8 minor

Most severe, free to view

  • MetoclopramideA03FA01severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe

34 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N05AA02

Levomepromazine, as other registers publish it.

All levomepromazine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1a1bc4b2-5718-4840-a5fc-72781f7c33bb
GET /v1/drugs/1a1bc4b2-5718-4840-a5fc-72781f7c33bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "tabletter",
  "source": "dkma",
  "strength": "25 mg",
  "auth_role": "CMS",
  "dk_drugid": "28107158724",
  "substance": "LEVOMEPROMAZINMALEAT",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": false,
  "registration_date_serial": "45919"
}
API referenceMCP serverPlans

See everything about levomepromazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console